Tag: side effects
-
Fournier’s Gangrene Is A Side Effect Of Farxiga, Invokana, Jardiance, And Other SGLT2 Inhibitor Diabetes Drugs — Or Is It?
At The Recent American Diabetes Association (ADA) Scientific Sessions There Was An Expression Of Doubt About Warnings For This Association (Posted by Tom Lamb at DrugInjuryWatch.com) In August 2018 the FDA required…
-
Xeljanz Warning For Increased Risk Of Blood Clots And Death With Higher Dose Used For Ulcerative Colitis
"Black Box Warning" For Xeljanz 10 mg Twice Daily Dose Required By FDA In July 2019 Follows Regulatory Action In Europe (Posted by Tom Lamb at DrugInjuryWatch.com) A Xeljanz FDA Drug Safety…
-
Lemtrada: Reports Of Serious Cardiovascular Events And Immune-Mediated Reactions Under Investigation
UK Drug Safety Regulator MHRA Imposes Lemtrada Use Restrictions And Mandates Patient Monitoring For Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) In May 2019 the UK's Medicines and Healthcare products Regulatory…
-
June 2019 Actemra Label Change Adds Warnings About Increased Risks Of Liver Injury After Months Or Years Of Use
Serious Cases Of Hepatic Injury Some Of Which Have Resulted In Liver Transplant Or Death Reported As Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) On May 21, 2019 we posted this…
-
Xeljanz Related Blood Clots Can Cause Pulmonary Embolism (PE) Or Deep Vein Thrombosis (DVT) With Patient Deaths Possible
Serious Side Effects For Xeljanz 10 mg Dose Found In Pfizer Post-Marketing Study Leads To New European Drug Safety Regulatory Action (Posted by Tom Lamb at DrugInjuryWatch.com) The serious side effects associated…
-
FDA: More Reports Of Diabetes Drugs Invokana, Jardiance, And Farxiga Being Associated With Fournier’s Gangrene
Serious Infection In The Genital Area Seems to Be A Drug Class Side Effect Of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors (Posted by Tom Lamb at DrugInjuryWatch.com) A new FDA analysis article published in…
-
Lemtrada Review By European Drug Regulatory Agency Covers Various Serious Side Effects In MS Patients
EMA Will Investigate Reports Of Associated Conditions Beyond Those That Were In November 2018 FDA Drug Safety Communication (Posted by Tom Lamb at DrugInjuryWatch.com) We recently learned by means of this April…
-
Xeljanz Recommended Dosage For Ulcerative Colitis Patients May Increase Risk Of Pulmonary Embolism
FDA Is Reviewing Safety Of Xeljanz 10 mg Twice-Daily Dose Of This JAK Inhibitor, According to February 2019 News Reports (Posted by Tom Lamb at DrugInjuryWatch.com) UPDATE: FDA Drug Safety Communication: "Safety…
-
Uloric Recall, “Black-Box Warning”, And Limited Use Discussed By FDA Advisory Committees In January 2019
Despite Drug Safety Problem Of Cardiovascular Mortality, Benefits Might Be Seen To Outweigh Risks For Select Gout Patients (Posted by Tom Lamb at DrugInjuryWatch.com) Uloric (febuxostat) was approved by the FDA in…